ArticleImprovement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type IIAuthor:Charles JFPublish date: September 1, 2010 Rituximab is a B-cell depleting monoclonal antibody targeting CD20. Data concerning the behavior of psoriatic disease following rituximab therapy ...Read More
